Pharming Group

Pharming is a global, commercially staged biopharmaceutical company dedicated to developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The flagship product in our portfolio is our recombinant human C1 esterase inhibitor, C1INH, a naturally occurring protein that downregulates the complement cascade to control swelling in affected tissues.